Skip to content

Clinical trials

Phase 3 Uveitis, Posterior trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uveitis, Posterior Phase: Phase 3 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20091
20105
20111
20122
20142
20152
20171
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated8
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
XOMA (US) LLC3
Clearside Biomedical, Inc.2
EyePoint Pharmaceuticals, Inc.2
Lux Biosciences, Inc.2
AbbVie1
Institut de Recherches Internationales Servier1
Novartis1
Priovant Therapeutics, Inc.1
Texas Retina Associates1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uveitis, Posterior20
Uveitis, Intermediate19
Uveitis18
Panuveitis15
Uveitis, Anterior3
Behcet Syndrome2
Cardiovascular Diseases1
Dermatitis1
Myocardial Infarction1
Psoriasis1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.